Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer
Xue-Hui Chen, Zhi-Qiang Li, Hua Peng, Su-Mei Jin, Hui-Qing Fu, Tie-Chui Zhu, Xiao-Gang WengThe First Affiliated Hospital of Xinxiang Medical University, Weihui, People's Republic of ChinaAbstract: One of the most important molecules mediating the proliferation, growth, and metastasis of canc...
Main Authors: | Chen XH, Li ZQ, Peng H, Jin SM, Fu HQ, Zhu TC, Weng XG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-05-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/type-1-insulin-like-growth-factor-receptor-monoclonal-antibody-hx-1162-a13049 |
Similar Items
-
Studies with monoclonal antibodies to the human insulin receptor
by: Soos, M. A.
Published: (1986) -
Preparation, characterisation and application of monoclonal antibodies reactive with the type I insulin-like growth factor receptor
by: Field, Catherine Elizabeth
Published: (1992) - Policy and practice: an analysis of 2001 Florida State Bill 1162
-
Studies of insulin receptor internalization and down-regulation using monoclonal antibodies
by: Ganderton, Rosalind Helen
Published: (1989) -
Bipolar – Valued Q – Fuzzy Hx Subgroup on an Hx Group
by: Mourad Oqla MASSA'DEH, et al.
Published: (2017-04-01)